FDA
approval
· 2025-09-30
FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar RxLLC)
Summary
FDA approved the supplemental application for a generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide for treatment of hypertension, ma…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)